Iterum Therapeutics plc ITRMF

Full chart Compare
Set alert

Price alert · ITRMF

All alert types
0.05 USD 0.00 (+0.00%)

Jul 6, 2026, 9:39 AM EDT

0.0499 Day range 0.05
0.005 52-week range 1.28
YTD
-85.10%
1 year
-92.34%

Revenue & Expenses

Other Income → Expenses: $196.00KExpenses → Selling, General & Admin: $11.28MExpenses → Research & Development: $90.77MExpenses → Interest Expense: $861.00KExpenses → Income Tax: $444.00KGross Profit → Expenses: $37.00KRevenue → Gross Profit: $37.00KNet Loss → Expenses: $103.13MOther Income$196.00KGross Profit$37.00KNet Loss$103.13MExpenses$103.36MSelling, General & Admin$11.28MResearch & Development$90.77MInterest Expense$861.00KIncome Tax$444.00KRevenue$37.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

ITRMF annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-254.00K0000
-18.70M-47.47M-30.38M-24.54M-32.13M
-24.77M-38.37M-44.43M-91.56M-52.01M
-1.26-2.96-3.63-8.41-32.49
ITRMF annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
24.16M6.11M21.13M27.51M14.57M
44.59M26.26M66.83M91.51M32.79M
48.68M32.66M38.83M41.27M83.35M
45.53M18.96M28.47M26.52M42.34M
-4.08M-6.40M28.00M50.23M-50.56M
ITRMF annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-26.77M-39.33M-18.47M-15.84M-54.53M
18.21M23.34M13.96M-54.59M-11.00K
26.69M1.03M-1.82M83.13M64.47M
-2.00K-13.00K-62.00K-61.00K-11.00K
18.05M-15.02M-6.38M12.69M9.93M